Newsroom

Get in Touch

Krishna Knabe
Director of Communications

Alzheimer's Matters Blog

Top 5 Alzheimer's Advances in 2017

ADDF Impact

Top Five Alzheimer’s Advances in 2017

Our top five advances in 2017 spotlight the substantial progress we have made toward conquering Alzheimer’s and other neurodegenerative diseases.

Developing Drugs

Alzheimer’s Biomarkers, Explained

Learn what a biomarker is, why they matter to the ADDF, which biomarkers we have, and which ones we need.  

Dr. Roberta Diaz Brinton

Developing Drugs

Closing in on a Cure: Dr. Roberta Diaz Brinton and Allopregnanolone

With funding from the ADDF since 2004, Dr. Roberta Diaz Brinton has developed what may become the first ever regenerative treatment for Alzheimer's disease.

Resources

Featured Video

Developed by Dr. Roberta Diaz Brinton, allopregnanolone could become the first regenerative therapy for Alzheimer's. Support from the ADDF helped Dr. Brinton turn her idea into a therapy that is now in phase 2 clinical trials.

View more on our YouTube channel

Fact Sheets & Publications